Investments accounted for using equity method, acquired

No definition available.

Name:	abx_InvestmentsAccountforUsingEquityMethodAcquired
Namespace Prefix:	abx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Investments accounted for using equity method, dividend

+ References

No definition available.

+ Details

Name:	abx_Investmentsaccountedforusingequitymethoddividend
Namespace Prefix:	abx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfJointVenturesLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of impairment loss, impairment gain or reversal of impairment loss that is recognised in profit or loss in accordance with paragraph 5.5.8 of IFRS 9 and that arises from applying the impairment requirements in Section 5.5 of IFRS 9.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2018-01-01
-Name IAS
-Number 1
-IssueDate 2017-01-01
-Paragraph 82
-Subparagraph ba
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=1&date=2017-03-01&anchor=para_82_ba&doctype=Standard
-URIDate 2017-03-09

+ Details

Name:	ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2017-01-01
-Paragraph 24
-Subparagraph a
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=8&date=2017-03-01&anchor=para_24_a&doctype=Standard
-URIDate 2017-03-09

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2017-01-01
-Paragraph B16
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=12&date=2017-03-01&anchor=para_B16&doctype=Appendix&seq=2
-URIDate 2017-03-09

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2017-01-01
-Paragraph 54
-Subparagraph e
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=1&date=2017-03-01&anchor=para_54_e&doctype=Standard
-URIDate 2017-03-09

+ Details

Name:	ifrs-full_InvestmentAccountedForUsingEquityMethod
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2017-01-01
-Paragraph 23
-Subparagraph g
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=8&date=2017-03-01&anchor=para_23_g&doctype=Standard
-URIDate 2017-03-09

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2017-01-01
-Paragraph 28
-Subparagraph e
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=8&date=2017-03-01&anchor=para_28_e&doctype=Standard
-URIDate 2017-03-09

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2017-01-01
-Paragraph 82
-Subparagraph c
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=1&date=2017-03-01&anchor=para_82_c&doctype=Standard
-URIDate 2017-03-09

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective on first application of IFRS 9
-Name IFRS
-Number 4
-IssueDate 2017-01-01
-Paragraph 39M
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=4&date=2017-03-01&anchor=para_39M_b&doctype=Standard
-URIDate 2017-03-09

+ Details

Name:	ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	ifrs-full_JointVenturesAxis=ifrs-full_JointVenturesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_JointVenturesAxis=abx_KabangaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_JointVenturesAxis=abx_JabalSayidMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_JointVenturesAxis=abx_ZaldivarMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_JointVenturesAxis=abx_GNXMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

EQUITY ACCOUNTING METHOD INVESTMENT CONTINUITY (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Disclosure of joint ventures [line items]
Investments, beginning balance			$ 1,213
Equity pick-up (loss) from equity investees	$ (10)	$ (14)	(26)	$ (25)
Investments, ending balance	1,214		1,214		$ 1,213
Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9	59	$ (5)	61	(1,130)
Joint ventures [member]
Disclosure of joint ventures [line items]
Investments, beginning balance			1,213	1,185	1,185
Equity pick-up (loss) from equity investees			26		76
Funds invested			5		12
Dividend					(60)
Investments, ending balance	1,214		1,214		1,213
Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9			(30)
Kabanga [Member]
Disclosure of joint ventures [line items]
Investments, beginning balance			30	30	30
Equity pick-up (loss) from equity investees			0		(1)
Funds invested			0		1
Dividend					0
Investments, ending balance	0		0		30
Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9			(30)
Jabal Sayid
Disclosure of joint ventures [line items]
Investments, beginning balance			206	180	180
Equity pick-up (loss) from equity investees			19		26
Funds invested			0		0
Dividend					0
Investments, ending balance	225		225		206
Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9			0
Zaldívar
Disclosure of joint ventures [line items]
Investments, beginning balance			975	974	974
Equity pick-up (loss) from equity investees			14		61
Funds invested			0		0
Dividend					(60)
Investments, ending balance	989		989		975
Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9			0
GNX
Disclosure of joint ventures [line items]
Investments, beginning balance			2	$ 1	1
Equity pick-up (loss) from equity investees			(7)		(10)
Funds invested			5		11
Dividend					0
Investments, ending balance	$ 0		0		$ 2
Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9			$ 0